 Don’t miss our top 5 cancer-related stories this month,
including a guest commentary from an industry leader, our two-part series on
trends in cancer research and more!
By E. Kevin Hrusovsky, PerkinElmer Inc. As the complexity and volume of data continue to rise, bioinformatics is emerging as one of the cornerstones of personalized medicine, from enabling discovery and development of novel treatments and diagnostics to facilitating collection, analysis and interpretation of data that ultimately helps an individual patient. SPECIAL REPORT PART 1: ‘Good enough’ is no longer good enough By Randall Willis, ddn Features Editor Aiming beyond the standard of care in oncology By Randall Willis, ddn Features Editor Are we really making things better for cancer patients? High-profile oncology partnership By Jim Cirigliano, ddn Contributing Editor Araxes Pharma and Janssen Biotech ink oncology drug development deal Natural neighbors By Kelsey Kaustinen, ddn Features Editor OSU, Biosortia link up to identify natural products for potential cancer treatments  |
 Clinical Genomics Center established by Lab21, ITOR
April 2012
SHARING OPTIONS:
“Bringing this leading-edge technology to the cancer clinic
represents a significant breakthrough and the culmination of a seven-year
journey,” Dr. Joe Stephenson, medical director for ITOR, noted in a statement.
“This genomics center is another major step towards fulfilling our vision to
provide personalized cancer care—better enabling us to offer the right drug, at
the right time, to the right patient.” Back |
       |
||
|
 
|
 |
© Copyright 2013 Old River Publications LLC. All righs reserved. | Web site managed and designed by OffWhite.